Director, Chairperson & CEO · UNITED THERAPEUTICS Corp · Common Stock
Side
SELL
Value
$119K
Shares
200
Price
$593.14
Executed
Nov 5, 2026
Disclosed
Nov 6, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Nov 5 executedNov 6, 2026 disclosed
UTHR · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Rothblatt Martine A filed this Form 4 reporting a open-market sale of UTHR on Nov 5, 2026. It became public on Nov 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chairperson & CEO
Rothblatt Martine Acik:0001106578
Issuer
UNITED THERAPEUTICS Corpcik:0001082554
Revision history · 0
No field has changed since this record was first ingested.
